相关实验视频

Updated: Jul 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

关于肝细胞癌的临床和病理更新

Salvatore Lorenzo Renne^1,2, Luca Di Tommaso^1,2

¹Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Journal of liver cancer

|June 29, 2023

概括

到2025年,肝细胞癌 (HCC) 每年影响超过100万. 使用组织生物标志物识别分子子组可以改善患者的治疗分配,并鼓励治疗前的活检.

科学领域:

在瘤学瘤学.
病理学病理学病理学
分子生物学分子生物学

背景情况:

肝细胞癌 (HCC) 是一个重要的全球健康问题,预测到2025年,每年将有超过100万个新病例.
HCC表现出不同的分子子组,每个与特定的形态和表型特征相关.
了解这些分子差异对于推进HCC诊断和治疗至关重要.

研究的目的:

要突出分子亚型在肝细胞癌 (HCC) 的重要性.
强调组织生物标志物在临床病理学中对HCC患者管理的作用.
探索如何改进的诊断策略可以影响临床决策关于预治疗活检.

主要方法:

对HCC亚组的分子和遗传背景的分析.
评估与HCC亚型相关的形态和表型特征.
对生物标志物融入常规病理学实践的潜在影响的审查.

主要成果:

在HCC.中识别了两个主要的分子子组.
特定分子子组和不同的形态/表型特征之间的相关性.
证明组织生物标志物对患者分层的有用性.

结论:

肝癌的分子亚型为疾病异质性提供了关键的见解.
将组织生物标志物纳入病理学实践可以提高HCC患者的治疗分配.
通过利用生物标志物提高诊断准确度,可能会增加治疗前活检的频率,有助于针对HCC进行个性化医疗方法.

关键词:

血管新生调节剂血管新生调节剂癌瘤的癌症是什么诊断诊断诊断诊断诊断预测预后预测预测瘤微环境是一个微环境.肝细胞细胞肝细胞细胞

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

相关概念视频

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...